Shares of UnitedHealth Group (NYSE: UNH) were pulling back Thursday after the company delivered underwhelming fourth-quarter results, as sales were weaker than expected and its costs rose.
As of 1:15 p.m. ET, the stock was down 5.2%.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks »
Revenue in the quarter rose by 6.8% to $100.8 billion, which missed the analysts' consensus estimate of $101.7 billion.
In its insurance division, UnitedHealthCare, revenue rose 4.7% to $74.1 billion as it added millions of customers during the year, continuing to expand its base. Revenue from Optum, its division that provides patient care and manages pharmacy benefits, rose 9.4% to $65.1 million. (There are areas of revenue overlap across the divisions.)
UnitedHealth's profit margin fell from 5.8% to 5.5% with declines in both UnitedHealthcare and Optum, and its medical loss ratio -- i.e., the percentage of premiums paid out for patient care -- rose to 87.6%. Management forecast that the ratio will be in the range of 86% to 87% for 2025, while the analysts' average target was 86%.
On the bottom line, the company reported adjusted earnings per share of $6.81, up from $6.18 a year ago, as it benefited from a lower tax rate and adjustments for costs related to a cyberattack. That was slightly better than the consensus estimate of $6.74.
Looking ahead to 2025, UnitedHealth reaffirmed its outlook, calling for revenue of $450 billion to $455 billion, and adjusted earnings per share of $29.50 to $30.
Higher medical expenses and tighter payment policies from the government have put pressure on the earnings of UnitedHealth and its peers, and some legislators in Congress are calling for large pharmacy benefit managers like OptumRx to be broken up.
While UnitedHealth still expects steady growth in 2025, the broad pressure on the healthcare industry remains, and higher loss ratios offer reason for investors to be cautious.
Before you buy stock in UnitedHealth Group, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $834,951!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
See the 10 stocks »
*Stock Advisor returns as of January 13, 2025
Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.